• Fund Type: SICAV
  • Objective: Health Care Sector
  • Asset Class: Equity
  • Geographic Focus: International

Candriam Equities L Biotechnology

+ Add to Watchlist

DEXEBTN:LX

335.04 USD 5.08 1.49%

As of 00:59:30 ET on 09/30/2014.

Snapshot for Candriam Equities L Biotechnology (DEXEBTN)

Year To Date: +20.79% 3-Month: +7.91% 3-Year: +41.24% 52-Week Range: 250.34 - 341.88
1-Month: +0.35% 1-Year: +26.39% 5-Year: +26.65% Beta vs BTK: 0.91

Mutual Fund Chart for DEXEBTN

No chart data available.
  • DEXEBTN:LX 335.04
  • 1M
  • 1Y
Interactive DEXEBTN Chart

Previous Close

No chart data available.
Interactive Chart
  • 1W
  • 1M
  • YTD
  • 1Y
  • 3Y
  • 5Y
Close:
Open:
High:
Low:
Volume:
Recently Viewed Symbols
Save as Watchlist
Saving as watchlist...

Fund Profile & Information for DEXEBTN

Candriam Equities L - Biotechnology is a SICAV incorporated under the laws of Luxembourg. The Fund's objective is capital appreciation. The Fund invests in global biotechnology stocks. Because the sector is currently experiencing the highest growth in the U.S., at least two-thirds of the Fund's assets will be invested in U.S. biotechnology stocks.

Inception Date: 08-23-2002 Telephone: 352-254-3431
Managers: RUDI VAN DEN EYNDE
Web Site: www.candriam.com

Fundamentals for DEXEBTN

NAV (on 2014-09-30) 335.04
Assets (M) (on 2014-09-30) 608.73
Fund Leveraged N
Minimum Investment -
Minimum Subsequent Investment -

Dividends for DEXEBTN

No dividends reported

Fees & Expenses for DEXEBTN

Front Load 0.00
Back Load 0.00
Current Mgmt Fee 2.00
Redemption Fee 0.00
12b1 Fee -
Expense Ratio 2.23

Top Fund Holdings for DEXEBTN

Filing Date: 08/29/2014
Name Position Value % of Total
Gilead Sciences Inc 524,000 56,371,920 9.162%
Celgene Corp 539,000 51,215,780 8.324%
Amgen Inc 348,000 48,504,240 7.883%
Biogen Idec Inc 114,000 39,106,560 6.356%
Alexion Pharmaceuticals Inc 174,500 29,541,105 4.801%
Regeneron Pharmaceuticals Inc 78,000 27,340,560 4.444%
Illumina Inc 105,000 18,832,800 3.061%
Vertex Pharmaceuticals Inc 200,000 18,714,000 3.042%
BioMarin Pharmaceutical Inc 198,000 14,101,560 2.292%
Salix Pharmaceuticals Ltd 76,000 12,092,360 1.965%

Quotes delayed, except where indicated otherwise. Mutual fund NAVs include dividends. All prices in local currency. Time is ET.

Sponsored Link
Advertisement
Advertisement
Sponsored Links
Advertisements
sec ||= nil